Structure and biological interactions of heparin and heparan sulfate

[61] Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J]. NATURE, 1998, 393 (6687) : 812 - 817

[62] Design and synthesis of heparin mimetics able to inhibit thrombin. Part 1 - Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation' [J]. CARBOHYDRATE RESEARCH, 1999, 317 (1-4) : 63 - 84

[63] Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition [J]. CARBOHYDRATE RESEARCH, 1999, 317 (1-4) : 85 - 99

[64] GRADIENT POLYACRYLAMIDE-GEL ELECTROPHORESIS FOR DETERMINATION OF MOLECULAR-WEIGHTS OF HEPARIN PREPARATIONS AND LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVES [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) : 823 - 827

[65] EDGE ASB, 1990, J BIOL CHEM, V265, P15874

[66] Engelberg H, 1996, PHARMACOL REV, V48, P327

[67] ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (05) : 387 - 444

[68] Pyranose ring flexibility. Mapping of physical data for iduronate in continuous conformational space [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (09) : 2099 - 2107

[69] Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum [J]. BIOCHEMICAL JOURNAL, 1996, 315 : 589 - 597

[70] Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4182 - 4187

[61] Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J]. NATURE, 1998, 393 (6687) : 812 - 817

[62] Design and synthesis of heparin mimetics able to inhibit thrombin. Part 1 - Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation' [J]. CARBOHYDRATE RESEARCH, 1999, 317 (1-4) : 63 - 84

[63] Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition [J]. CARBOHYDRATE RESEARCH, 1999, 317 (1-4) : 85 - 99

[64] GRADIENT POLYACRYLAMIDE-GEL ELECTROPHORESIS FOR DETERMINATION OF MOLECULAR-WEIGHTS OF HEPARIN PREPARATIONS AND LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVES [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) : 823 - 827

[65] EDGE ASB, 1990, J BIOL CHEM, V265, P15874

[66] Engelberg H, 1996, PHARMACOL REV, V48, P327

[67] ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (05) : 387 - 444

[68] Pyranose ring flexibility. Mapping of physical data for iduronate in continuous conformational space [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (09) : 2099 - 2107

[69] Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum [J]. BIOCHEMICAL JOURNAL, 1996, 315 : 589 - 597

[70] Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4182 - 4187